Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-02-05
1984-12-11
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424319, A61K 3130, A61K 31195
Patent
active
044877803
ABSTRACT:
Rheumatoid arthritis is treated with substituted cysteine compounds having a lower toxicity-to-effectiveness ratio than penicillamine. Such compounds are specific alpha-substituted cysteines, beta-monosubstituted cysteines, beta-di-substituted cysteines other than penicillamine, N-acetyl penicillamine and the N-acetyl derivatives of the alpha and beta-substituted compounds mentioned above.
Any of the compounds may be used synergistically in combination with suitable copper compounds or with suitable gold compounds in the treatment of arthritis.
The same compounds are effective in the treatment of cystinuria and heavy metal poisoning. The same compounds as well as penicillamine are effective in combination with copper in the treatment of heavy metal poisoning.
REFERENCES:
patent: 3466312 (1969-09-01), Ercoli
patent: 3591686 (1971-07-01), Sheffner et al.
patent: 3792165 (1974-02-01), McGusty et al.
patent: 3842108 (1974-10-01), Sutton et al.
patent: 4112113 (1978-09-01), Hill
patent: 4165380 (1979-08-01), Hill
LandOfFree
Method of treatment of rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1462982